{"id":71466,"date":"2026-05-20T12:20:00","date_gmt":"2026-05-20T12:20:00","guid":{"rendered":"https:\/\/medsbase.com\/b12-cyanocobalamin\/"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"b12-cyanocobalamin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/b12-cyanocobalamin\/","title":{"rendered":"Vitamin B12 (Cyanocobalamin) Injectable \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es la inyecci\u00f3n de B12 (Cianocobalamina)?<\/h3>\n<p style=\"margin: 0;\"><strong>Vitamina B12 (Cianocobalamina)<\/strong> es la forma sint\u00e9tica ciano-coordinada de la familia de coenzimas cobalaminas (CAS 68-19-9, MF C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P, MW 1355,37 g\/mol). Suministrado aqu\u00ed como un <strong>vial inyectable multidosis de 10 mg por 10 mL<\/strong> (1 mg\/mL pre-formulated sterile aqueous solution \u2014 no reconstitution required) for studies and companion-protocol use alongside the peptide catalogue. Cyanocobalamin is the most-cited B12 form in published studies because it is the most chemically stable: cells take it up via the transcobalamin-II \/ cubilin pathway and convert it intracellularly to the two biologically-active cobalamin forms \u2014 <strong>metilcobalamina<\/strong> (cofactor para la metionina sintasa\/ciclo SAM\/metabolismo de un carbono) y <strong>adenosilcobalamina<\/strong> (cofactor for methylmalonyl-CoA mutase \/ odd-chain fatty acid metabolism \/ TCA entry). For clinical studies use only. <em>No es un p\u00e9ptido<\/em> \u2014 coenzima corrinoide centrada en cobalto de peque\u00f1a mol\u00e9cula.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pre-formulated sterile aqueous solution \u00b7 \u226599% HPLC-verified cyanocobalamin \u00b7 COA available on request \u00b7 Discreet temperature-controlled packaging \u00b7 Worldwide peptide courier \u00b7 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Clase de compuesto<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Coenzima corrinoide centrada en cobalto; familia de la vitamina B12; cofactor de peque\u00f1a mol\u00e9cula; <em>no es un p\u00e9ptido<\/em><\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Nombre qu\u00edmico<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Cianocobalamina (sin\u00f3nimos: Vitamina B12, cobalamina (forma ciano), CN-B12; la forma sint\u00e9tica estabilizada con cianuro de la familia de las cobalaminas)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">68-19-9 (cianocobalamina); CAS de cobalaminas relacionadas \u2014 metilcobalamina 13422-55-4, hidroxocobalamina 13422-51-0, adenosilcobalamina 13870-90-1 (no suministrada aqu\u00ed)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1355.37 g\/mol<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Mecanismo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">La cianocobalamina entra en las c\u00e9lulas mediante la v\u00eda mediada por receptores transcobalamina-II \u2192 cubilina y se convierte intracelularmente por la metionina sintasa reductasa (MTRR) y la prote\u00edna cblA de aciduria metilmal\u00f3nica (MMAA) en las dos coenzimas de cobalamina biol\u00f3gicamente activas \u2014 <strong>metilcobalamina<\/strong> (cofactor citos\u00f3lico para la metionina sintasa) y <strong>adenosilcobalamina<\/strong> (cofactor mitocondrial para la metilmalonil-CoA mutasa). Ambos coenzimas son esenciales para el metabolismo de un carbono\/metilaci\u00f3n y propionil-CoA\/\u00e1cidos grasos de cadena impar, respectivamente.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">n\/a (corrinoide de mol\u00e9cula peque\u00f1a \u2014 no es un p\u00e9ptido)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma y concentraci\u00f3n<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Soluci\u00f3n acuosa est\u00e9ril preformulada<\/strong> \u2014 1 mg\/mL cyanocobalamin in physiological-buffer base, 10 mL multi-dose vial (10 mg total cyanocobalamin per vial). Characteristic deep red colour from the cobalt-corrin chromophore. <strong>No requiere reconstituci\u00f3n<\/strong> \u2014 extraer as\u00e9pticamente con jeringa est\u00e9ril.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC); est\u00e1ndar de referencia de cianocobalamina grado USP. COA disponible bajo solicitud.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Altamente soluble en agua (~12.5 mg\/mL de l\u00edmite de solubilidad a 25 \u00b0C); la soluci\u00f3n preformulada est\u00e1 muy por debajo de la saturaci\u00f3n. Estable en tamp\u00f3n acuoso a pH 4\u20137. Evitar condiciones alcalinas (formaci\u00f3n r\u00e1pida de hidroxocobalamina) y condiciones fuertemente reductoras (generaci\u00f3n de cob(II)alamina).<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Refrigerar a 2\u20138 \u00b0C; <strong>proteger de la luz<\/strong> (la cianocobalamina es fotosensible \u2014 la luz UV\/azul cataliza la conversi\u00f3n de ciano a hidroxi). Usar el vial multidosis dentro de los 60 d\u00edas posteriores a la primera punci\u00f3n. No congelar (la formaci\u00f3n de cristales de hielo puede agrietar el vial de vidrio y existe riesgo de degradaci\u00f3n fotol\u00edtica durante el almacenamiento prolongado en congelaci\u00f3n). Usar antes de la fecha de caducidad indicada en la etiqueta del vial (normalmente 24 meses desde la fabricaci\u00f3n).<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es la vitamina B12 (cianocobalamina)?<\/h2>\n<p><strong>Cianocobalamina<\/strong> (CAS 68-19-9) es la forma sint\u00e9tica ciano-coordinada de la familia de coenzimas cobalaminas de la vitamina B12. Estructuralmente es un corrinoide complejo centrado en cobalto: un anillo macroc\u00edclico de 19 \u00e1tomos (el anillo de corrina, similar en geometr\u00eda al anillo de porfirina de la hemoglobina pero distinto en composici\u00f3n) coordina un ion cobalto central en su estado de oxidaci\u00f3n 3+, con una cola de nucle\u00f3tido de dimetilbencimidazol colgando debajo del anillo y un grupo ciano (-CN) ocupando la posici\u00f3n axial superior. F\u00f3rmula molecular C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P, molecular weight 1355.37 g\/mol. The molecule is intensely red \u2014 its visible-spectrum absorption (\u03bbmax ~360, ~520, ~550 nm) is what gives B12 solutions their characteristic deep pink-red colour. The &#8220;cyano&#8221; form is a synthetic stabilisation choice rather than a biologically-significant species in vivo. Cobalamins in cells exist primarily as <strong>metilcobalamina<\/strong> (un grupo metilo en la posici\u00f3n axial superior \u2014 el cofactor citos\u00f3lico para la metionina sintasa) y <strong>adenosilcobalamina<\/strong> (a 5\u2032-deoxyadenosyl group on the upper axial position \u2014 the mitochondrial cofactor for methylmalonyl-CoA mutase). These two active forms are interconverted by dedicated cellular enzymes and are not commercially supplied in stable injectable form because of their light-sensitivity. Cyanocobalamin is supplied instead because the cyano group is photochemically and thermally stable, and cells convert cyanocobalamin to the methyl and adenosyl forms intracellularly via methionine synthase reductase (MTRR) and the methylmalonic aciduria cblA-type protein (MMAA), respectively. In the studies and clinical context, cyanocobalamin injectable preparations are the canonical supplemental form. The 10 mL multi-dose vial format (1 mg\/mL \u00d7 10 mL = 10 mg per vial) supplied here matches the standard pharmaceutical preparation pattern. MedsBase stocks this format in the peptide-studies catalogue as a small-molecule companion compound used in protocols that combine peptide studies with cobalamin-axis biology \u2014 recovery, methylation-cycle studies, hematology, cognitive studies with nootropic peptides, and energy-metabolism panels where the SAM cycle is engaged. <\/p>\n<h2>Mecanismo de acci\u00f3n \u2014 Dos reacciones de coenzimas cobalaminas<\/h2>\n<p>El mecanismo biol\u00f3gico de la B12 \/ cianocobalamina es la suma de las dos reacciones enzim\u00e1ticas catalizadas por las coenzimas cobalaminas activas derivadas de ella:<\/p>\n<ul>\n<li><strong>Captaci\u00f3n celular v\u00eda transcobalamina-II \u2192 cubilina \/ megalina<\/strong> \u2014 La cianocobalamina libre en el l\u00edquido extracelular se une a la transcobalamina-II (TCII), y el complejo TCII-B12 es captado por el sistema de receptores cubilina \/ megalina en las superficies celulares. La liberaci\u00f3n intracelular en el lisosoma es seguida por transporte al citosol mediante el complejo de eflujo LMBRD1 \/ ABCD4.<\/li>\n<li><strong>Conversi\u00f3n intracelular a coenzimas activas<\/strong> \u2014 En el citosol, la metionina sintasa reductasa (MTRR) reduce y metila la cianocobalamina a <strong>metilcobalamina<\/strong> (la forma citos\u00f3lica activa), perdiendo el grupo ciano como cianuro (que luego es detoxificado por el sistema rodanasa \/ tiosulfato en las cantidades m\u00ednimas generadas). En la mitocondria, la prote\u00edna del tipo cblA de aciduria metilmal\u00f3nica (MMAA) m\u00e1s la metionina sintasa reductasa convierte la cianocobalamina en <strong>adenosilcobalamina<\/strong> (la forma mitocondrial activa).<\/li>\n<li><strong>Metilcobalamina \u2192 metionina sintasa (citos\u00f3lica, ciclo de un carbono \/ SAM)<\/strong> \u2014 La metionina sintasa cataliza la transferencia de un grupo metilo desde el 5-metil-tetrahidrofolato a la homociste\u00edna, regenerando metionina y tetrahidrofolato. Este es el v\u00ednculo cr\u00edtico entre la B12, el folato y el ciclo de metionina \/ SAM. El SAM (S-adenosil-metionina, generado a partir de metionina + ATP) es el donante universal de metilo celular para los cientos de reacciones de metilaci\u00f3n celular \u2014 metilaci\u00f3n del ADN, metilaci\u00f3n de histonas, metilaci\u00f3n de fosfol\u00edpidos, metilaci\u00f3n de neurotransmisores (catecolaminas, melatonina), bios\u00edntesis de creatina. La deficiencia de B12, por tanto, interrumpe todo el programa de metilaci\u00f3n de la c\u00e9lula y es la base molecular de las secuelas hematol\u00f3gicas (anemia megalobl\u00e1stica por s\u00edntesis de timidina dependiente de metilaci\u00f3n del ADN alterada) y neurol\u00f3gicas (desmielinizaci\u00f3n por metilaci\u00f3n de fosfol\u00edpidos alterada) de la deficiencia cl\u00ednica de B12.<\/li>\n<li><strong>Adenosilcobalamina \u2192 metilmalonil-CoA mutasa (mitocondrial, entrada de propionil-CoA \/ TCA)<\/strong> \u2014 La metilmalonil-CoA mutasa cataliza el reordenamiento intramolecular del (R)-metilmalonil-CoA a succinil-CoA. Este es el punto de entrada metab\u00f3lica para sustratos generadores de propionil-CoA \u2014 \u00e1cidos grasos de cadena impar, amino\u00e1cidos de cadena ramificada (valina, isoleucina, metionina), cadena lateral del colesterol. La deficiencia de adenosilcobalamina causa acumulaci\u00f3n de metilmalonato (el biomarcador diagn\u00f3stico de deficiencia cl\u00ednica de B12) y perjudica la oxidaci\u00f3n de propionil-CoA \/ grasas de cadena impar.<\/li>\n<li><strong>Conexi\u00f3n con el eje NAD y cruce del metabolismo de un carbono<\/strong> \u2014 La reacci\u00f3n de B12 \/ metionina sintasa se sit\u00faa en el mismo nodo metab\u00f3lico que las reacciones de metilaci\u00f3n consumidoras de SAM catalizadas por cientos de metiltransferasas celulares, incluyendo la NNMT (nicotinamida N-metiltransferasa) \u2014 el objetivo de <a href=\"https:\/\/medsbase.com\/es\/5-amino-1mq\/\">5-Amino-1MQ<\/a>. NNMT consumes SAM to methylate nicotinamide; impaired B12 \/ methionine-synthase function lowers cellular SAM availability and therefore lowers NNMT activity indirectly. Studies that probes the NAD-axis \/ one-carbon-metabolism crossover often co-administers B12 and NNMT-pathway tools to dissect these connected biochemistries.<\/li>\n<\/ul>\n<p>The pharmacokinetic profile of injectable cyanocobalamin is well-characterised: IM or SC administration produces rapid systemic absorption with peak plasma concentrations at 1\u20132 hours; substantial dose-dependent renal clearance (the kidney saturates and dose-dumps any cyanocobalamin above the transcobalamin-II carrier capacity); cellular uptake then proceeds over hours-to-days; conversion to active coenzymes happens continuously thereafter; and the very low daily turnover requirement of cobalamin coenzymes (~2 \u00b5g\/d in human physiology) means that single high-dose injections produce sustained tissue-level effects for weeks. The 1 mg\/mL \u00d7 10 mL multi-dose format supports typical protocols ranging from single-bolus high-dose work to weekly or daily smaller-dose chronic dosing. <\/p>\n<h2>Published Evidence<\/h2>\n<p>B12 \/ cyanocobalamin is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>One-carbon metabolism and SAM-cycle studies<\/strong> \u2014 the canonical small-molecule cofactor for methionine synthase; standard tool compound for any studies that probes the folate \/ B12 \/ methionine \/ SAM axis; widely used in DNA-methylation and histone-methylation pharmacology studies<\/li>\n<li><strong>Homocysteine-axis studies<\/strong> \u2014 methionine synthase deficiency \/ impairment causes homocysteine accumulation; cyanocobalamin supplementation is the standard intervention in published studies models of hyperhomocysteinaemia and cardiovascular risk<\/li>\n<li><strong>Haematology and erythropoiesis studies<\/strong> \u2014 B12 deficiency causes megaloblastic anaemia via impaired DNA-methylation-dependent thymidine synthesis; published studies uses cyanocobalamin in vitamin-deficiency erythropoiesis models, bone-marrow culture studies, and reticulocyte-response studies<\/li>\n<li><strong>Peripheral neuropathy and demyelination studies<\/strong> \u2014 B12 deficiency causes peripheral neuropathy and subacute combined degeneration of the spinal cord via impaired phospholipid methylation in myelin sheaths; published studies uses cyanocobalamin supplementation in demyelination \/ remyelination model systems<\/li>\n<li><strong>NAD-axis \/ methylation crossover studies<\/strong> \u2014 combinada con <a href=\"https:\/\/medsbase.com\/es\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (inhibidor de NNMT) o <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD\u207a<\/a> in published studies that probes the SAM-cycle \/ nicotinamide-methylation node<\/li>\n<li><strong>Recovery and athletic-applications (combined with peptide protocols)<\/strong> \u2014 frequently included as a companion compound in protocols that combine peptide therapeutics (BPC-157, TB-500, GH peptides) with cofactor \/ vitamin support; the canonical small-molecule companion to peptide-axis recovery<\/li>\n<li><strong>Cognitive and nootropic-applications<\/strong> \u2014 combinado con p\u00e9ptidos cognitivos (<a href=\"https:\/\/medsbase.com\/es\/selank\/\">Selank<\/a>, <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a>, <a href=\"https:\/\/medsbase.com\/es\/dsip\/\">DSIP<\/a>) in studies on the cognitive sequelae of B12 deficiency and the cobalamin axis in CNS function<\/li>\n<li><strong>Cyanocobalamin vs methylcobalamin vs hydroxocobalamin comparative studies<\/strong> \u2014 published studies has compared the four cobalamin forms head-to-head for bioavailability, intracellular conversion kinetics, and tissue-retention profiles; cyanocobalamin is the canonical reference compound against which the others are benchmarked<\/li>\n<\/ul>\n<p>For broader context on small-molecule cofactor \/ coenzyme compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/es\/l-carnitine\/\">L-Carnitina<\/a> (the closest small-molecule companion analogue \u2014 mitochondrial long-chain fatty-acid shuttle), <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD\u207a<\/a> (coenzima dinucle\u00f3tido oxidada \u2014 suplementaci\u00f3n directa del pool de NAD), <a href=\"https:\/\/medsbase.com\/es\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (inhibidor de NNMT \u2014 conecta el ciclo de B12\/metionina con el eje NAD), y <a href=\"https:\/\/medsbase.com\/es\/mots-c\/\">MOTS-c<\/a> (p\u00e9ptido metab\u00f3lico derivado mitocondrial). Explore el <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">peptides &amp; compounds catalog<\/a>. <\/p>\n<h2>Tama\u00f1os de paquete disponibles<\/h2>\n<p>MedsBase dispone de Vitamina B12 (Cianocobalamina) Inyectable en un \u00fanico formato de concentraci\u00f3n\/vial con tres opciones de tama\u00f1o de paquete:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1o del paquete<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Material total<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1 Vial<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Single-experiment, dose-titration, or short-course in-vivo studies \u2014 10 mg total cyanocobalamin in 10 mL multi-dose format covers 4\u20138 weeks of typical protocol dosing in rodents or small-cohort cell-culture work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 mg \/ 10 mL<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 Viales<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Multi-cohort or extended-cycle studies \u2014 typical mid-scale protocols using B12 as a companion compound alongside peptide-dosing; per-vial economics improve significantly vs single-vial purchase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50 mg \/ 50 mL<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 Viales<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Large-cohort or long-arm protocols \u2014 chronic-dosing companion supply alongside long-cycle peptide protocols; lowest per-mg cost; covers multi-animal cohort work without re-purchase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100 mg \/ 100 mL<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The single 1-vial pack is convenient for single-experiment or titration work; the 5-vial and 10-vial packs provide significant per-vial savings for chronic protocols or multi-cohort studies. The 1 mg\/mL \u00d7 10 mL multi-dose format matches the standard pharmaceutical injectable cyanocobalamin pattern and is well-suited to typical protocol dosing \u2014 IM, SC, or IV administration of 100 \u00b5g to 1 mg per dose (equivalent to 0.1\u20131 mL of the supplied solution) covers essentially all published studies dose ranges. <\/p>\n<h2>Comparativa \u2014 B12 (Cianocobalamina) frente a L-Carnitina<\/h2>\n<p>La B12 y <a href=\"https:\/\/medsbase.com\/es\/l-carnitine\/\">L-Carnitina<\/a> are the two best-characterised small-molecule companion compounds in this catalogue. Both serve as cofactor \/ shuttle compounds in mitochondrial and metabolic support, both are supplied in multi-dose injectable formats appropriate for protocol use alongside the peptide catalogue, and both are mechanistically distinct from the peptide compounds. The comparison illustrates the two canonical &#8220;small-molecule companion&#8221; compounds that users add to peptide protocols. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">B12 (Cianocobalamina)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">L-Carnitina<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Clase qu\u00edmica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Coenzima corrinoide centrada en cobalto (mol\u00e9cula peque\u00f1a \u00fanica)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Derivado de amino\u00e1cido con amonio cuaternario (zwitteri\u00f3n \u00fanico)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1355.37 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">161,20 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Funci\u00f3n celular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cofactor \u2014 metionina sintasa (citos\u00f3lica, ciclo SAM) + metilmalonil-CoA mutasa (mitocondrial, propionil-CoA \u2192 TCA)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Transportador de sustrato \u2014 transporte de \u00e1cidos grasos de cadena larga a trav\u00e9s de la membrana mitocondrial interna (entrada a la \u03b2-oxidaci\u00f3n)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">One-carbon \/ methylation, homocysteine axis, megaloblastic erythropoiesis, demyelination studies, cognitive \/ nootropic crossover<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fat oxidation, mitochondrial bioenergetics, insulin sensitivity, sperm motility, cardiovascular metabolic support<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Aprobaci\u00f3n de la FDA<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">S\u00ed \u2014 la cianocobalamina inyectable est\u00e1 aprobada para la deficiencia de vitamina B12; la hidroxocobalamina est\u00e1 aprobada como Cyanokit (ant\u00eddoto para cianuro)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">S\u00ed \u2014 la levocarnitina est\u00e1 aprobada para deficiencia primaria\/secundaria de carnitina (oral e intravenosa)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Requerimiento diario de recambio<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Muy bajo (~2 \u00b5g\/d en fisiolog\u00eda humana) \u2014 inyecciones \u00fanicas de dosis altas mantienen niveles tisulares durante semanas<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Alto \u2014 el pool end\u00f3geno de carnitina es de ~25 g; el requerimiento diario de reemplazo en estados de deficiencia es considerable<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Forma suministrada<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Soluci\u00f3n acuosa est\u00e9ril preformulada (1 mg\/mL \u00d7 10 mL multidosis)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Polvo liofilizado (reconstituir con agua BAC)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dosis t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100 \u00b5g a 1 mg por dosis (0,1\u20131 mL de la soluci\u00f3n suministrada), IM \/ SC \/ IV<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cientos de mg hasta niveles de gramo por dosis (protocolos en roedores \/ animales grandes)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on one-carbon metabolism, SAM cycle, homocysteine axis, or megaloblastic erythropoiesis, B12 \/ cyanocobalamin is the canonical small-molecule companion. For studies focused on long-chain fatty-acid oxidation, mitochondrial bioenergetics, or insulin sensitivity, <a href=\"https:\/\/medsbase.com\/es\/l-carnitine\/\">L-Carnitina<\/a> is the more targeted tool. The two compounds are commonly co-administered as part of broader peptide-protocols that benefit from both methylation-cycle and fatty-acid-oxidation cofactor support. <\/p>\n<h2>Almacenamiento y manipulaci\u00f3n<\/h2>\n<p><strong>Soluci\u00f3n preformulada \u2014 no requiere reconstituci\u00f3n.<\/strong> A diferencia de los productos pept\u00eddicos liofilizados de este cat\u00e1logo, la cianocobalamina inyectable se suministra como una soluci\u00f3n acuosa est\u00e9ril lista para usar. Extraer as\u00e9pticamente con una jeringa est\u00e9ril en cada uso; no introducir contaminantes en el vial multidosis. <strong>Almacenamiento:<\/strong> refrigerar a 2\u20138 \u00b0C en el envase original. <strong>Proteger de la luz en todo momento<\/strong> \u2014 cyanocobalamin is photosensitive (UV and short-wavelength visible light catalyses cyano-to-hydroxo and cyano-to-cob(II)alamin photoproducts). Store the vial in its original light-protective box or wrap in foil if removed. Avoid prolonged exposure to clinical ambient light during handling. <strong>No congelar.<\/strong> La formaci\u00f3n de cristales de hielo puede agrietar el vial de vidrio, y el almacenamiento congelado no ofrece beneficios de estabilidad adicionales respecto a la refrigeraci\u00f3n para una soluci\u00f3n acuosa ya formulada. La soluci\u00f3n es estable a 2\u20138 \u00b0C durante al menos 24 meses desde la fecha de fabricaci\u00f3n en estado sin abrir. <strong>Tras el primer uso:<\/strong> utilizar el vial multidosis en un plazo de 60 d\u00edas. El tamp\u00f3n preformulado incluye conservantes (normalmente alcohol benc\u00edlico o fenol en concentraciones farmac\u00e9uticas) que mantienen la esterilidad durante el uso multidosis, pero las punciones acumulativas del septo eventualmente pueden permitir la entrada de microorganismos. Desechar si aparece turbidez, part\u00edculas, cambio notable de color (especialmente p\u00e9rdida del rojo intenso caracter\u00edstico \u2014 indica fotodegradaci\u00f3n) o precipitaci\u00f3n. <\/p>\n<h2>Preguntas frecuentes<\/h2>\n<h3>\u00bfPor qu\u00e9 la soluci\u00f3n de B12 suministrada tiene un color rojo intenso?<\/h3>\n<p>El anillo de corrina centrado en cobalto de las cobalaminas es un crom\u00f3foro potente en el espectro visible \u2014 las bandas de absorbancia \u03bbmax de la cianocobalamina a ~360 nm (UV), ~520 nm (verde) y ~550 nm (verde-amarillo) producen el caracter\u00edstico color rojo-rosado transmitido. Cualquier soluci\u00f3n de cianocobalamina debe presentar un color rojo intenso; si se torna amarillento o marr\u00f3n indica fotodegradaci\u00f3n (conversi\u00f3n a hidroxocobalamina o reducci\u00f3n a cob(II)alamina) y el vial debe desecharse. <\/p>\n<h3>\u00bfPor qu\u00e9 este producto de B12 utiliza la forma ciano en lugar de metil- o hidroxocobalamina?<\/h3>\n<p>Cyanocobalamin is the standard form supplied as injectable B12 because it is photochemically and thermally the most stable of the cobalamin forms \u2014 the cyano group resists the photolytic degradation that affects methyl-, hydroxo-, and adenosylcobalamin in solution. Once cyanocobalamin enters cells, intracellular enzymes (MTRR, MMAA) convert it to the biologically-active methylcobalamin and adenosylcobalamin forms. For most applications, cyanocobalamin is therefore the practical choice. Users specifically studying methylcobalamin or hydroxocobalamin pharmacology (e.g., differential cellular-uptake kinetics, light-degradation pathways, or cyanide-antidote applications) require those specific forms separately. <\/p>\n<h3>\u00bfEs este producto de B12 un p\u00e9ptido?<\/h3>\n<p>No. La cianocobalamina es una coenzima corrinoide centrada en cobalto de bajo peso molecular (MW 1355.37 g\/mol), <em>ajuste<\/em> a peptide. We stock it in our peptide-studies catalogue as the canonical small-molecule companion compound used in protocols that combine peptide studies with cobalamin-axis biology. The spec table Sequence row is marked &#8220;n\/a&#8221; for this reason. Other small-molecule companions in this catalogue include <a href=\"https:\/\/medsbase.com\/es\/l-carnitine\/\">L-Carnitina<\/a>, <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD\u207a<\/a>, <a href=\"https:\/\/medsbase.com\/es\/5-amino-1mq\/\">5-Amino-1MQ<\/a>, y <a href=\"https:\/\/medsbase.com\/es\/aicar-acadesine\/\">AICAR<\/a>. <\/p>\n<h3>What published dose ranges have been used in studies?<\/h3>\n<p>Injectable cyanocobalamin published dosing in human-clinical and rodent in-vivo work typically uses 100\u20131000 \u00b5g per dose (0.1\u20131.0 mL of the supplied 1 mg\/mL solution), IM or SC, daily for the first week and then weekly or monthly thereafter for chronic protocols. The 1000 \u00b5g single bolus is the canonical &#8220;loading dose&#8221; in clinical-translational studies. In-vitro cell-culture protocols typically use nanomolar to micromolar concentrations. Users should consult primary literature appropriate to the specific application (haematology, neuropathy, cardiovascular, one-carbon metabolism, etc.). <\/p>\n<h3>Can B12 be combined with peptides like Selank, Semax, or DSIP in protocols?<\/h3>\n<p>S\u00ed \u2014 la B12 se combina frecuentemente con p\u00e9ptidos nootr\u00f3picos (<a href=\"https:\/\/medsbase.com\/es\/selank\/\">Selank<\/a>, <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a>, <a href=\"https:\/\/medsbase.com\/es\/dsip\/\">DSIP<\/a>) in studies on the cognitive sequelae of cobalamin deficiency and the broader cobalamin-axis contribution to CNS function. B12 is also commonly co-administered with recovery peptides (BPC-157, TB-500), growth-hormone peptides (<a href=\"https:\/\/medsbase.com\/es\/sermorelin\/\">Sermorelin<\/a>, <a href=\"https:\/\/medsbase.com\/es\/tesamorelin\/\">Tesamorelin<\/a>) y p\u00e9ptidos metab\u00f3licos (<a href=\"https:\/\/medsbase.com\/es\/mots-c\/\">MOTS-c<\/a>) como cofactor complementario. La forma acuosa preformulada permite extraerla fresca en una jeringa separada para cada administraci\u00f3n \u2014 no mezclar con otras soluciones de p\u00e9ptidos en la misma jeringa, ya que el crom\u00f3foro de corrina de cobalto puede interactuar con p\u00e9ptidos que contienen tiol e inducir efectos fotoredox menores. <\/p>\n<h3>\u00bfPor qu\u00e9 a veces se menciona la cianocobalamina junto al cianuro?<\/h3>\n<p>The cyano group on cyanocobalamin is a very small amount of bound cyanide \u2014 when intracellular enzymes convert cyanocobalamin to the active methyl\/adenosyl forms, free cyanide is released in stoichiometric amount, but the quantity is very small (~25 \u00b5g of cyanide per 1 mg of cyanocobalamin) and is detoxified by the cellular rhodanese \/ thiosulfate system without clinical significance. The opposite reaction \u2014 cobalamin scavenging cyanide \u2014 is the basis of hydroxocobalamin&#8217;s approved use as a cyanide-antidote drug (Cyanokit), where high-dose hydroxocobalamin sequesters circulating cyanide as cyanocobalamin for renal excretion. Users in cyanide-antidote studies require hydroxocobalamin specifically, not cyanocobalamin. <\/p>\n<h3>How does this pharmaceutical-grade B12 compare with the existing branded B12 products on MedsBase?<\/h3>\n<p>Los productos de B12 con marca existentes en MedsBase (p. ej., <a href=\"https:\/\/medsbase.com\/es\/vitamin-b12\/\">Vitamin B12 1500 mcg Tablets<\/a>) are clinical-pharmaceutical-grade B12 packaged in tablet form for oral \/ sublingual use, positioned in the nerve-health \/ energy-supplement category. The pharmaceutical-grade B12 supplied here is the injectable cyanocobalamin form in 10 mL multi-dose vial format, positioned in the peptide-studies catalogue as a small-molecule companion alongside the peptide compounds. Users requiring an oral \/ sublingual B12 supplement should use the tablet products; users requiring injectable cyanocobalamin for in-vivo or cell-culture work alongside peptide protocols can use the material supplied here. <\/p>\n<h3>\u00bfEst\u00e1 la B12 en la Lista de Sustancias Prohibidas de la AMA?<\/h3>\n<p>No. La vitamina B12\/cianocobalamina no est\u00e1 en la Lista de Sustancias Prohibidas de la AMA. Es un compuesto vitam\u00ednico\/cofactor com\u00fanmente utilizado tanto cl\u00ednicamente (para el tratamiento de la deficiencia de B12) como suplemento permitido en contextos atl\u00e9ticos. No hay restricciones regulatorias en el rendimiento atl\u00e9tico para la cianocobalamina u otras formas de cobalamina. <\/p>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 20px 0 8px; border-radius: 4px; font-size: 14px;\"><strong>Why order compounds from MedsBase:<\/strong> Lyophilized HPLC \u226599% peptides &amp; compounds \u00b7 COA available on request \u00b7 Discreet protective packaging \u00b7 Worldwide courier \u00b7 <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance<\/a> en cada pedido \u00b7 M\u00e1s de 1,400 verificados <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Small-Molecule Companion Compounds<\/h2>\n<ul>\n<li><a href=\"\/es\/l-carnitine\/\"><strong>L-Carnitina<\/strong><\/a> \u2014 Mitochondrial fatty-acid shuttle \u2014 closest small-molecule companion analogue<\/li>\n<li><a href=\"\/es\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Oxidised dinucleotide coenzyme \u2014 direct NAD-pool supplementation studies<\/li>\n<li><a href=\"\/es\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2014 Inhibidor de NNMT \u2014 conecta el ciclo de B12\/metionina con la metilaci\u00f3n del eje NAD<\/li>\n<li><a href=\"\/es\/aicar-acadesine\/\"><strong>AICAR<\/strong><\/a> \u2014 Canonical small-molecule AMPK activator \u2014 companion metabolic support compound<\/li>\n<li><a href=\"\/es\/mots-c\/\"><strong>MOTS-c<\/strong><\/a> \u2014 Mitochondrial-derived metabolic peptide \u2014 alternative-mechanism cofactor studies<\/li>\n<li><a href=\"\/es\/bac-water\/\"><strong>Agua BAC (Agua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 Necesaria para reconstituir cualquier vial liofilizado \u2014 diluyente est\u00e9ril conservado con alcohol benc\u00edlico al 0.9%<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Coenzima corrinoide centrada en cobalto \u2014 familia de la vitamina B12 (CAS 68-19-9)<br \/>\n\u2705 Soluci\u00f3n acuosa est\u00e9ril preformulada (no requiere reconstituci\u00f3n)<br \/>\n\u2705 1 mg\/mL \u00d7 10 mL multi-dose vial (10 mg total cyanocobalamin)<br \/>\n\u2705 Cofactor de la metionina sintasa celular + metilmalonil-CoA mutasa<br \/>\n\u2705 Small-molecule companion compound (MW 1355.37, USP-grade)<\/p>\n<p><strong>Vitamina B12 (Cianocobalamina) Inyectable<\/strong> contiene 1 mg\/mL \u00d7 10 mL de soluci\u00f3n est\u00e9ril de cianocobalamina.<\/p>","protected":false},"featured_media":71536,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6511,6510,6512,6513,6515,6514,3862],"class_list":["post-71466","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-cobalamin","product_tag-cyanocobalamin","product_tag-methionine-synthase-cofactor","product_tag-methylation-research","product_tag-research-companion","product_tag-small-molecule-research-compound","product_tag-vitamin-b12","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/71466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=71466"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/71536"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=71466"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=71466"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=71466"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=71466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}